Australian (ASX) Stock Market Forum

IVG - Invert Graphite

Jump to new
Re: TIS - Tissue Therapies

TIS share price has a habbit of putting on a big run after the capital raising (during which time the share price remain below the raising price)... as if just to punish speculators for not having faith in the company.
 
Re: TIS - Tissue Therapies

Anyone still holding this? I am, and have been holding for a month or so waiting for a few nice announcements, such as today's. Opened a good 14% higher than friday on the announcement (CE Mark approval), but ended up closing down 2%. Can't for the life of me work it out. Can anyone share any light?
 
Re: TIS - Tissue Therapies

The last 6 months haven't exactly been party time for TIS holders:

imageChart.gif

There's been more cap-raising / sophisticated issues / rights issues, and the board remains upbeat. Been an awful long time since any real progress was manifest to the market.

So I think we're entering crunch-time? Either the European regulators give TIS's product their seal of approval, or they withhold for whatever reasons, and TIS cops a whipping.

Recent rights issue has just gone ex-entitlement, and we'll soon see the extent of shareholders' take-up (but note that the issues to sophs are already bagged, and that's where most of the aimed for $12 mill is coming from).

I'm looking to take a position. Current SP is $0.255 c.

I'll sleep on it till Monday ...

Discl: don't hold, (& haven't)
 
Re: TIS - Tissue Therapies

Currently in a trading halt pending "... an announcement regarding regulatory approvals ..." or is that regulatory disapprovals, I wonder.

Having recently acquired a few, I'm awaiting the presumed release of news this coming Monday with both hope and trepidation.

bioshares.com.au/ recently issued a sector overview which mentioned that "we expect European approval (anticipated mid 2013) to be a modest catalyst for Tissue Therapies’ share price.", so the forthcoming announcement is not that ? (hence it could be a disapproval / request for further details type of situation ...?)

Fingers crossed for a reversal of the downtrend on a pleasant surprise, but if not, c'est la vie.
 
Re: TIS - Tissue Therapies

History records that shortly after Country Lad's wise words of reservation, and my misplaced optimism (and more misplaced investment) Tissue Therapies became a by-word for failure, a case study in how to botch the quest for regulatory approval, and how to pass off blissful ignorance as somebody else's mis-step.

The avoidance of ignorance is the duty of management. Regulatory refusal/deferral is one thing. To be called out by a regulator for not correctly categorising ones "product" or is that "medicine" is a nuance that should have been carefully assessed and prepared for long ago.

I think it was Tallyrand who said: "it was worse than failure - it was a blunder". :banghead:

Last SP $0.16. Fell as low as 12c (from 25c ) on the news, clawed back a little over the following days.

Anyway, I spat it out. TIS may further recover from here, but that good fortune if it happens I leave to smile on others.
 
Re: TIS - Tissue Therapies

Regulatory approvals (CE mark) coming out soon.

Its 210 days waiting period is up for Regulatory approvals and now on extra time cos' of request for additional info. from regulatory body.

It has been a long roller coaster ride for me.
 
Re: TIS - Tissue Therapies

Setting up nicely for a six-month investment with a price target pf 0.496. Technical buying signal at au stoxline.
 
On May 5th, 2016, Tissue Therapies Limited (TIS) changed its name and ASX code to Factor Therapeutics Limited (FTT).
 
On October 29th, 2021, Factor Therapeutics Limited (FTT) changed its name and ASX code to Dominion Minerals Limited (DLM).
 
On January 8th, 2025, Dominion Minerals Limtied (DLM) changed its name and ASX code to Invert Graphite Limited (IVG).
 
Top